Thursday, July 5, 2012 Wednesday, July 4, 2012- Monti’s Cuts May Cost Italians New Pills as Drug Firms Protestat Bloomberg (Wed, 4 Jul)
- Go Long On AstraZeneca Nowat Seeking Alpha (Wed, 4 Jul)
- Boeing ELEVATES on Outlook and 4 Dazzling Dow Driversat Wall St. Cheat Sheet (Wed, 4 Jul)
- Johnson & Johnson Deserving Of Its Upgradesat Seeking Alpha (Wed, 4 Jul)
- A High Income, Low Risk Portfolio: Six Months Resultsat Seeking Alpha (Wed, 4 Jul)
- Duisburg Back From Brink Gives German Lesson in Economic Revivalat Bloomberg (Wed, 4 Jul)
- Pipeline Progresses at J&JZacks (Wed, 4 Jul)
- Pfizer's Potential Game-Changing Drugs Great For Investorsat Motley Fool (Wed, 4 Jul)
- Retirement: Enjoyment Without Employment - Paths Of Choice (Part 8)at Seeking Alpha (Wed, 4 Jul)
- Dividend Growth Portfolio: 2012 Mid-Year Updateat Seeking Alpha (Wed, 4 Jul)
- Is Abbott Labs' Run Higher About to End?at Motley Fool (Wed, 4 Jul)
Tuesday, July 3, 2012- [video] They Just Don't Get Glaxo!at TheStreet (Tue, 3 Jul)
- 5 Cash-Heavy Dividend Stocks Sporting Analyst Confidenceat Seeking Alpha (Tue, 3 Jul)
- New Lawsuit Will Not Damage GlaxoSmithKline Stockat Motley Fool (Tue, 3 Jul)
- Prefer Quality Stocks With High Dividend Yield Over U.S. Treasury Bondsat Seeking Alpha (Tue, 3 Jul)
- The Zacks Analyst Blog Highlights: Johnson & Johnson, Zimmer Holdings, Smith & Nephew, General Motors and Toyota MotorZacks (Tue, 3 Jul)
- Baxter, NeoStem Duel For Next-Gen Heart Disease Stem Cell Therapyat Seeking Alpha (Tue, 3 Jul)
- Healthcare Biz Review: J&J’s NEW TB Drug, Arena GIVES BACK Againat Wall St. Cheat Sheet (Tue, 3 Jul)
- Idenix: New HCV Drug Could Be A Blockbusterat Seeking Alpha (Tue, 3 Jul)
- 2 Dividend Stocks To Buy, 2 To Avoid, And 1 To Sell For Retireesat Seeking Alpha (Tue, 3 Jul)
- Comparing Prospects For Comparable Investments: Dow Stocksat Seeking Alpha (Tue, 3 Jul)
- Johnson & Johnson recalls K-Y LiquibeadsAP (Tue, 3 Jul)
- J&J seeks OK for first drug against resistant TBAP (Tue, 3 Jul)
- Shorts Are Piling Into These Stocks. Should You Be Worried?at Motley Fool (Tue, 3 Jul)
| |
|
0.09%